Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatment

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The study aim is to investigate the differences between sex and gender in the immune-related adverse events (irAEs) development associated with immune checkpoint inhibitors (ICI) treatment. The study will be a multicenter prospective observational study focusing on biological differences between females and males, possibly affecting discrepant irAEs incidence.
Epistemonikos ID: 1b09610a6b1bd688551c7f2fff286a47f31153a3
First added on: May 07, 2024